20-2816718-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001167670.3(TMEM239):c.164G>A(p.Arg55Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000497 in 1,548,108 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001167670.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM239 | NM_001167670.3 | c.164G>A | p.Arg55Gln | missense_variant | 2/2 | ENST00000380585.2 | NP_001161142.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM239 | ENST00000380585.2 | c.164G>A | p.Arg55Gln | missense_variant | 2/2 | 1 | NM_001167670.3 | ENSP00000369959.1 | ||
ENSG00000241690 | ENST00000380593.4 | c.435G>A | p.Ala145Ala | synonymous_variant | 3/3 | 2 | ENSP00000369967.4 | |||
TMEM239 | ENST00000361033.1 | c.293G>A | p.Arg98Gln | missense_variant | 2/2 | 2 | ENSP00000354312.1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152146Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000135 AC: 2AN: 147614Hom.: 0 AF XY: 0.0000127 AC XY: 1AN XY: 78598
GnomAD4 exome AF: 0.0000516 AC: 72AN: 1395844Hom.: 0 Cov.: 37 AF XY: 0.0000581 AC XY: 40AN XY: 688266
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152264Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74458
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 08, 2024 | The c.164G>A (p.R55Q) alteration is located in exon 2 (coding exon 1) of the TMEM239 gene. This alteration results from a G to A substitution at nucleotide position 164, causing the arginine (R) at amino acid position 55 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at